Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Diagnostic Accuracy of GPT-4o and Claude for HEART Score Calculation in Chest Pain (LLM-HEART)

22 de junio de 2026 actualizado por: Emir Ünal, Marmara University Pendik Training and Research Hospital

Diagnostic Accuracy of Large Language Models (GPT-4o and Claude) in HEART Score Calculation and 30-Day MACE Prediction in Emergency Department Chest Pain Patients: A Prospective Observational Validation Study Against Three-Expert Consensus

This prospective observational diagnostic accuracy study evaluates whether large language models (LLMs) - GPT-4o (OpenAI, gpt-4o-2024-11-20) and Claude (Anthropic, claude-sonnet-4-6) - can accurately calculate HEART scores from unstructured Turkish clinical notes and predict 30-day major adverse cardiac events (MACE) in emergency department patients presenting with non-traumatic chest pain.

The study will enroll 600 consecutive adult patients. For each patient, the same anonymized data (free-text anamnesis, ECG report text, troponin value, and age) will be independently processed by both LLMs via separate API calls with deterministic settings (temperature=0, JSON format). A three-expert consensus HEART score - derived through blinded independent scoring by three emergency medicine physicians with majority-vote adjudication - serves as the reference standard for agreement analysis. Actual 30-day MACE (all-cause death, AMI Type 1/2/4b, unplanned revascularization) determined via national health database and telephone follow-up serves as the outcome for diagnostic accuracy analysis.

A secondary documentation-quality sub-study will quantify how spontaneously Turkish emergency anamnesis notes capture HEART score parameters.

Descripción general del estudio

Descripción detallada

AI SYSTEM SPECIFICATIONS AND PROMPT PROTOCOL Two distinct large language models (LLMs) will be evaluated as index tests: OpenAI GPT-4o (model string: gpt-4o-2024-11-20) and Anthropic Claude (model string: claude-sonnet-4-6). To ensure reproducibility and eliminate stochastic variation, both models will be accessed via standardized API calls using deterministic parameters (temperature = 0, max_tokens = 500, and strict JSON response format). The exact system prompt layout will be locked prior to initialization, and its integrity will be verified using a SHA-256 cryptographic hash. The models will evaluate each patient record independently in zero-shot isolation, with no cross-contamination or conversational history retention between runs.

REFERENCE STANDARD CONSENSUS PROTOCOL The reference standard consists of a structured consensus HEART score established by three independent emergency medicine physicians (each possessing >=3 years of clinical experience and specific training on HEART score criteria). The physicians will review the anonymized clinical charts while remaining strictly blinded to the LLM outputs and the final 30-day MACE outcomes. For each of the 5 HEART components (scored 0, 1, or 2), a majority vote (2/3 agreement) will determine the final component score. In the event of complete disagreement across all three reviewers on a specific component, a fourth independent adjudicator will resolve the tie.

INDETERMINATE RESULTS MANAGEMENT

In strict compliance with STARD-AI 2025 guidelines, cases with missing or uninterpretable parameters within the free-text clinical notes will be classified into predefined indeterminate tiers:

  1. Complete Cases: 0 indeterminate components (eligible for primary diagnostic accuracy analysis).
  2. Partial Indeterminate: Exactly 1 missing component preventing definitive automatic calculation.
  3. Full Indeterminate: >=2 missing components. The proportion of indeterminate classifications will be quantified for both LLMs and evaluated alongside the routine documentation quality of the charts.

STATISTICAL ANALYSIS AND AGREEMENT WEIGHTING Statistical power and sample size calculation are based on the Hanley-McNeil methodology for the Area Under the ROC Curve (AUC). To achieve an expected AUC of 0.85 with a non-inferiority margin of 0.05, a power of 80%, and a two-sided alpha of 0.05, the primary complete-case analysis requires 600 evaluable patients. Accounting for an anticipated 15% indeterminate rate, a total enrollment target of 690 patients is set. Inter-rater agreement between each LLM and the expert consensus will be computed using quadratic weighted Cohen's Kappa for the ordinal total HEART score (0-10) and linear weighted Kappa for individual components (0-2). Diagnostic performance metrics (sensitivity, specificity, PPV, NPV) will be calculated at prespecified binary (>=4) and trimodal thresholds with 95% Wilson confidence intervals. Pairwise comparison of AUC values between GPT-4o and Claude will be executed using the DeLong test.

DATA ANONYMIZATION AND PRIVACY To ensure full compliance with local personal data protection legislation (KVKK), all free-text emergency department notes will undergo strict de-identification. Patient names, institutional ID numbers, precise dates, and specific demographic identifiers will be stripped entirely before formatting the data payload for API transmission.

PATIENT AND PUBLIC INVOLVEMENT BEYANI Patient and public involvement was not applicable to this study as it involves the analysis of routinely collected clinical data.

Tipo de estudio

De observación

Inscripción (Estimado)

690

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Emir Ünal, Assistant Professor
  • Número de teléfono: +905327766010
  • Correo electrónico: emirunal@gmail.com

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

    • Istanbul
      • Istanbul, Istanbul, Turquía (Türkiye), 34870
        • Reclutamiento
        • Marmara University Pendik Training and Research Hospital
        • Contacto:
        • Sub-Investigador:
          • Emre Kudu
        • Sub-Investigador:
          • Erhan Altunbas
        • Sub-Investigador:
          • Sinan Karacabey

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra no probabilística

Población de estudio

The study population consists of consecutive adult patients presenting with a chief complaint of non-traumatic chest pain to the emergency department of Marmara University Pendik Training and Research Hospital, a tertiary care academic medical center in Istanbul, Turkey. This target population comprises real-world emergency medicine admissions that require acute coronary syndrome risk stratification and evaluation with the HEART score. It excludes individuals presenting with traumatic pain etiologies or acute ST-elevation myocardial infarction (STEMI) requiring immediate, time-critical reperfusion pathways.

Descripción

INCLUSION CRITERIA:

  • Age >=18 years
  • Chief complaint of non-traumatic chest pain at the emergency department
  • Written informed consent obtained from the patient or legally authorized representative
  • Availability for 30-day follow-up (reachable by telephone and/or actively registered in the e-Nabiz national health database)

EXCLUSION CRITERIA:

  • Traumatic chest pain etiology
  • ST-elevation myocardial infarction (STEMI) at presentation requiring immediate reperfusion protocol
  • Refusal or subsequent withdrawal of informed consent
  • Inability to complete the mandatory 30-day follow-up period

WITHDRAWAL CRITERIA:

  • Patient or representative requests data withdrawal after initial consent
  • Administrative identification of retrospective data entry after enrollment

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Area Under the ROC Curve (AUC) of GPT-4o and Claude HEART Score for 30-Day MACE Prediction
Periodo de tiempo: 30 days after index emergency department visit
AUC calculated separately for GPT-4o and Claude using the Hanley-McNeil method. MACE is defined as a composite of all-cause death, acute myocardial infarction (Type 1/2/4b), and unplanned revascularization within 30 days. HEART score range is 0-10; a higher score indicates a higher risk of MACE. Analysis will be performed on complete cases only (0 indeterminate components).
30 days after index emergency department visit

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Sensitivity and Specificity of GPT-4o and Claude HEART Score at Prespecified Thresholds
Periodo de tiempo: 30 days after index emergency department visit
Diagnostic sensitivity and specificity calculated at two threshold types: (a) total score >=4 (binary high-risk cutoff) and (b) trimodal cutoffs (0-3 low risk, 4-6 intermediate risk, 7-10 high risk). Metrics will be reported with 95% Wilson confidence intervals separately for each LLM.
30 days after index emergency department visit
Component-Level and Total-Score Agreement (Cohen's Kappa) Between LLMs and Expert Consensus
Periodo de tiempo: Baseline (At index emergency department visit)
Inter-rater agreement will be computed using quadratic weighted Cohen's Kappa for the ordinal total HEART score (range 0-10) and linear weighted Kappa for the individual components (range 0-2). Calculated separately for GPT-4o vs. expert consensus and Claude vs. expert consensus. Values will be interpreted using the Landis & Koch scale (<0.20 poor, 0.21-0.40 fair, 0.41-0.60 moderate, 0.61-0.80 good, >0.80 excellent).
Baseline (At index emergency department visit)
Comparative AUC Difference Between GPT-4o and Claude (DeLong Test)
Periodo de tiempo: 30 days after index emergency department visit
Statistical comparison of paired ROC curves between GPT-4o and Claude using the DeLong et al. (1988) method. The formal hypothesis is non-inferiority with an expected delta AUC <= 0.05. The correlation coefficient between the paired LLM measurements is estimated as rho >= 0.70.
30 days after index emergency department visit
Proportion of Indeterminate Results for GPT-4o and Claude
Periodo de tiempo: Baseline (At index emergency department visit)
The proportion of cases classified into predefined missing data tiers: Complete (0 indeterminate components), Partial indeterminate (exactly 1 missing component preventing definitive score calculation), and Full indeterminate (>=2 missing components). Reported separately for each LLM and statistically compared between the two models.
Baseline (At index emergency department visit)
HEART Parameter Documentation Rate in Routine Turkish Anamnesis Notes
Periodo de tiempo: Baseline (At index emergency department visit)
For each of the 5 individual HEART components, the proportion of emergency department free-text anamnesis notes that spontaneously contain sufficient objective clinical information for scoring. Rates will be categorized as: Present and scorable, Partiall
Baseline (At index emergency department visit)
Subgroup AUC by Age Group and Sex (Algorithmic Bias Assessment)
Periodo de tiempo: 30 days after the index emergency department visit
AUC values for 30-day MACE prediction were calculated separately across demographic strata: age groups (<45, 45-64, >=65 years) and biological sex (male vs. female). This analysis serves as the formal algorithmic bias assessment required by the STARD-AI 2025 guidelines.
30 days after the index emergency department visit

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de junio de 2026

Finalización primaria (Estimado)

1 de marzo de 2027

Finalización del estudio (Estimado)

1 de junio de 2027

Fechas de registro del estudio

Enviado por primera vez

27 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

3 de junio de 2026

Publicado por primera vez (Actual)

4 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

23 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

22 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Anonymized individual participant data (including de-identified baseline demographics, clinical presentation characteristics, index test outputs from GPT-4o and Claude, and the reference standard expert consensus HEART scores) will be made publicly available to support academic transparency and replication. Additionally, the complete deterministic system prompt texts (verified with SHA-256 cryptographic hashes) and the complete statistical analysis code will be included as supplementary material.

Marco de tiempo para compartir IPD

The anonymized dataset, protocol documents, and analytic code will be made available immediately upon formal publication of the study results.

Criterios de acceso compartido de IPD

Data and code will be accessible via an open-access repository on the Open Science Framework (OSF) for researchers and clinicians interested in replication or meta-analysis.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CÓDIGO_ANALÍTICO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir